Midi Health vs Saffron Health
Side-by-side comparison of AI visibility scores, market position, and capabilities
Raised $100M Series D (Feb 2026) at $1B unicorn valuation. 230K+ patients in 50 states. Digital health's first menopause-focused unicorn. Expanding to longevity and cardiology.
About
Midi Health became digital health's first menopause-focused unicorn in February 2026, raising $100 million in Series D financing at a $1 billion valuation. The company serves 230,000+ patients across all 50 states with clinician-led care for menopause, perimenopause, and midlife women's health — a market that has been systematically underserved by mainstream healthcare despite affecting 50 million American women.
Saffron Health is a women's health digital therapeutics company providing AI-powered support for perimenopause, menopause, and hormonal health management. HQ: San Francisco.
About
Saffron Health is a digital health company focused on women's hormonal health — specifically supporting women navigating perimenopause and menopause through AI-powered health coaching, symptom tracking, personalized education, and care coordination with hormone replacement therapy providers. Founded to address the significant gap in menopause healthcare — where many women report that physicians don't discuss menopause proactively and many receive inadequate symptom management — Saffron provides a digital platform that empowers women with information, community, and clinical care access.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Midi Health vs
Saffron Health vs
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.